カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

4価髄膜炎菌ワクチンのグローバル市場2023：多糖体ワクチン、複合体ワクチン

■ 英語タイトル：Global Quadrivalent Meningococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11537）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11537
■ 発行日：2023年8月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[4価髄膜炎菌ワクチンのグローバル市場2023：多糖体ワクチン、複合体ワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、4価髄膜炎菌ワクチンのグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の4価髄膜炎菌ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 4価髄膜炎菌ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

4価髄膜炎菌ワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・多糖体ワクチン、複合体ワクチン

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・Sanofi-Pasteur、Walvax、Chengdu Kanghua Biological Products Co., Ltd.、Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.、Zhejiang Tianyuan Biopharmaceutical Co., Ltd.、Beijing Institute of Biological Products Co., Ltd.、CanSino Biological Co., Ltd.、Hualan Biological Vaccine Co., Ltd.、Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、4価髄膜炎菌ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な4価髄膜炎菌ワクチンメーカーの企業概要、2019年～2022年までの4価髄膜炎菌ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な4価髄膜炎菌ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別4価髄膜炎菌ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの4価髄膜炎菌ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での4価髄膜炎菌ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および4価髄膜炎菌ワクチンの産業チェーンを掲載しています。
・第14、15章では、4価髄膜炎菌ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 4価髄膜炎菌ワクチンの概要
– 種類別分析（2018年vs2022年vs2029年）：多糖体ワクチン、複合体ワクチン
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所
– 世界の4価髄膜炎菌ワクチン市場規模・予測
– 世界の4価髄膜炎菌ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sanofi-Pasteur、Walvax、Chengdu Kanghua Biological Products Co., Ltd.、Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.、Zhejiang Tianyuan Biopharmaceutical Co., Ltd.、Beijing Institute of Biological Products Co., Ltd.、CanSino Biological Co., Ltd.、Hualan Biological Vaccine Co., Ltd.、Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：多糖体ワクチン、複合体ワクチン
・用途別分析2018年-2029年：病院、診療所
・4価髄膜炎菌ワクチンの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・4価髄膜炎菌ワクチンのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・4価髄膜炎菌ワクチンのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・4価髄膜炎菌ワクチンの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・4価髄膜炎菌ワクチンの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Quadrivalent Meningococcal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Quadrivalent Meningococcal Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Polysaccharide Vaccine
1.3.3 Conjugate Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Quadrivalent Meningococcal Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Quadrivalent Meningococcal Vaccine Market Size & Forecast
1.5.1 Global Quadrivalent Meningococcal Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Quadrivalent Meningococcal Vaccine Sales Quantity (2018-2029)
1.5.3 Global Quadrivalent Meningococcal Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi-Pasteur
2.1.1 Sanofi-Pasteur Details
2.1.2 Sanofi-Pasteur Major Business
2.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product and Services
2.1.4 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi-Pasteur Recent Developments/Updates
2.2 Walvax
2.2.1 Walvax Details
2.2.2 Walvax Major Business
2.2.3 Walvax Quadrivalent Meningococcal Vaccine Product and Services
2.2.4 Walvax Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Walvax Recent Developments/Updates
2.3 Chengdu Kanghua Biological Products Co., Ltd.
2.3.1 Chengdu Kanghua Biological Products Co., Ltd. Details
2.3.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
2.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
2.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
2.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Details
2.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
2.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
2.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Details
2.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
2.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Beijing Institute of Biological Products Co., Ltd.
2.6.1 Beijing Institute of Biological Products Co., Ltd. Details
2.6.2 Beijing Institute of Biological Products Co., Ltd. Major Business
2.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.6.4 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
2.7 CanSino Biological Co., Ltd.
2.7.1 CanSino Biological Co., Ltd. Details
2.7.2 CanSino Biological Co., Ltd. Major Business
2.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.7.4 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CanSino Biological Co., Ltd. Recent Developments/Updates
2.8 Hualan Biological Vaccine Co., Ltd.
2.8.1 Hualan Biological Vaccine Co., Ltd. Details
2.8.2 Hualan Biological Vaccine Co., Ltd. Major Business
2.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.8.4 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
2.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
2.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Details
2.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
2.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
2.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Quadrivalent Meningococcal Vaccine by Manufacturer
3.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Quadrivalent Meningococcal Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Quadrivalent Meningococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Quadrivalent Meningococcal Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Quadrivalent Meningococcal Vaccine Manufacturer Market Share in 2022
3.5 Quadrivalent Meningococcal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Quadrivalent Meningococcal Vaccine Market: Region Footprint
3.5.2 Quadrivalent Meningococcal Vaccine Market: Company Product Type Footprint
3.5.3 Quadrivalent Meningococcal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Quadrivalent Meningococcal Vaccine Market Size by Region
4.1.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Quadrivalent Meningococcal Vaccine Average Price by Region (2018-2029)
4.2 North America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.3 Europe Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.5 South America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2018-2029)
5.3 Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2018-2029)
6.3 Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Quadrivalent Meningococcal Vaccine Market Size by Country
7.3.1 North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Quadrivalent Meningococcal Vaccine Market Size by Country
8.3.1 Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Quadrivalent Meningococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Quadrivalent Meningococcal Vaccine Market Size by Country
10.3.1 South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Quadrivalent Meningococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Quadrivalent Meningococcal Vaccine Market Drivers
12.2 Quadrivalent Meningococcal Vaccine Market Restraints
12.3 Quadrivalent Meningococcal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Quadrivalent Meningococcal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Quadrivalent Meningococcal Vaccine
13.3 Quadrivalent Meningococcal Vaccine Production Process
13.4 Quadrivalent Meningococcal Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Quadrivalent Meningococcal Vaccine Typical Distributors
14.3 Quadrivalent Meningococcal Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi-Pasteur Major Business
Table 5. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product and Services
Table 6. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi-Pasteur Recent Developments/Updates
Table 8. Walvax Basic Information, Manufacturing Base and Competitors
Table 9. Walvax Major Business
Table 10. Walvax Quadrivalent Meningococcal Vaccine Product and Services
Table 11. Walvax Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Walvax Recent Developments/Updates
Table 13. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 15. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 16. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 18. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Major Business
Table 20. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 21. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 23. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Major Business
Table 25. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 26. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 28. Beijing Institute of Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Beijing Institute of Biological Products Co., Ltd. Major Business
Table 30. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 31. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Beijing Institute of Biological Products Co., Ltd. Recent Developments/Updates
Table 33. CanSino Biological Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. CanSino Biological Co., Ltd. Major Business
Table 35. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 36. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. CanSino Biological Co., Ltd. Recent Developments/Updates
Table 38. Hualan Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Hualan Biological Vaccine Co., Ltd. Major Business
Table 40. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 41. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hualan Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 43. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Major Business
Table 45. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product and Services
Table 46. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments/Updates
Table 48. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Quadrivalent Meningococcal Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Quadrivalent Meningococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Quadrivalent Meningococcal Vaccine Production Site of Key Manufacturer
Table 53. Quadrivalent Meningococcal Vaccine Market: Company Product Type Footprint
Table 54. Quadrivalent Meningococcal Vaccine Market: Company Product Application Footprint
Table 55. Quadrivalent Meningococcal Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Quadrivalent Meningococcal Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Quadrivalent Meningococcal Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Quadrivalent Meningococcal Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Quadrivalent Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Quadrivalent Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Quadrivalent Meningococcal Vaccine Raw Material
Table 116. Key Manufacturers of Quadrivalent Meningococcal Vaccine Raw Materials
Table 117. Quadrivalent Meningococcal Vaccine Typical Distributors
Table 118. Quadrivalent Meningococcal Vaccine Typical Customers
List of Figures
Figure 1. Quadrivalent Meningococcal Vaccine Picture
Figure 2. Global Quadrivalent Meningococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Polysaccharide Vaccine Examples
Figure 5. Conjugate Vaccine Examples
Figure 6. Global Quadrivalent Meningococcal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Quadrivalent Meningococcal Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Quadrivalent Meningococcal Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Quadrivalent Meningococcal Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Quadrivalent Meningococcal Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Quadrivalent Meningococcal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Quadrivalent Meningococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Quadrivalent Meningococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Quadrivalent Meningococcal Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Quadrivalent Meningococcal Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Quadrivalent Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Quadrivalent Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Quadrivalent Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Quadrivalent Meningococcal Vaccine Market Drivers
Figure 73. Quadrivalent Meningococcal Vaccine Market Restraints
Figure 74. Quadrivalent Meningococcal Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Quadrivalent Meningococcal Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Quadrivalent Meningococcal Vaccine
Figure 78. Quadrivalent Meningococcal Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source

※参考情報

4価髄膜炎菌ワクチンは、髄膜炎菌（Neisseria meningitidis）による感染症を予防するためのワクチンです。この髄膜炎菌は、主に二次感染を引き起こす細菌であり、特に小児や若い成人に重大な脅威をもたらします。4価の意味は、このワクチンが4種類の髄膜炎菌の血清型に対する免疫応答を誘導することを指します。これらの血清型は、A、C、Y、W-135型として知られており、これらの型に感染すると、髄膜炎や敗血症などの重篤な病気を引き起こす可能性があります。

このワクチンは、主に死菌、もしくはポリサッカライド抗原を用いて作られており、体内に接種されることで免疫系がこれらの抗原を認識し、抗体を生成します。接種によって形成された抗体は、将来的に髄膜炎菌に感染した際に、速やかに病原体を排除するのに役立ちます。

4価髄膜炎菌ワクチンの特徴の一つは、その広範な保護範囲です。髄膜炎菌は、多様な血清群を持つため、特定の血清型に対するワクチンのみでは不十分であることがあります。そのため、4価ワクチンは特に保護が必要な人々にとって重要です。また、このワクチンは接種後の免疫効果が長期間持続することが期待されており、定期的な接種が推奨される場面もあります。

種類に関して、4価髄膜炎菌ワクチンは主に二種類に分類することができます。一つは、ポリサッカライドワクチンであり、このタイプのワクチンは髄膜炎菌の外層に存在するポリサッカライドを基に作られています。もう一つは、コンジュゲートワクチンで、これはポリサッカライドをタンパク質に結合させることで、より強い免疫応答を引き起こすことが可能です。コンジュゲートワクチンは、特に幼い子供に対して効果的とされており、より高い抗体の生成を促進します。

用途としては、4価髄膜炎菌ワクチンは特にリスクの高い集団に接種されます。例としては、大学生、特に寮生活を送る学生、そして医療従事者など、感染のリスクが高い環境にいる人々が挙げられます。また、旅行者においても、特定の地域に旅行する際には接種が推奨されることがあります。特に、髄膜炎菌が流行している地域へ旅行する場合、予防接種が重要です。

関連技術については、ワクチンの開発において使用される多くの技術が存在します。例えば、ナノ粒子技術やmRNA技術など、新たな製剤方法が研究されています。これらの技術を用いると、免疫系をターゲットにしたより効果的なワクチンの開発が期待されています。加えて、ワクチンの保存方法や配布方法も進化しており、冷蔵保存が難しい地域でも持続可能なワクチン供給が実現されつつあります。

4価髄膜炎菌ワクチンは、感染症予防の観点から重要な役割を果たしています。ワクチンの接種は、個人の免疫保護だけでなく、集団免疫の形成にも寄与し、感染症の流行を抑制する効果があります。特に新しいワクチン技術が進化する中で、より安全で効果的なワクチンが市場に登場することは、大きな期待を寄せられています。

最後に、ワクチン接種は、感染症の予防において非常に重要な手段であり、広く受け入れられています。医学的な予防策として、特に危険因子を持つ集団にはその効果が顕著です。このワクチンは、今後も多くの人々の健康を守るための重要な手段であり続けるでしょう。新たな知見や技術の進展により、さらなる効果的な予防策が開発されることが期待されます。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • グループA及びC髄膜炎菌多糖体ワクチンのグローバル市場2023：クラス1ワクチン、クラス2ワクチン
  • 髄膜炎菌ワクチンの世界市場 2023年-2027年
  • グループA及びグループC髄膜炎菌多糖体ワクチンの世界市場2023-2029：クラス1ワクチン、クラス2ワクチン
  • 世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 小反芻獣疫ワクチンのグローバル市場2023：混合ワクチン、非混合ワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11537 )"4価髄膜炎菌ワクチンのグローバル市場2023：多糖体ワクチン、複合体ワクチン" (英文：Global Quadrivalent Meningococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。